Wolverine Asset Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Wolverine Asset Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,560	Closed	-$298K	–	2347
2022 Q4	$298K	Buy	29,560 +10,660	+56%	+$106K	﹤0.01%	1059
2022 Q3	$187K	Buy	18,900 +1,621	+9%	+$16K	﹤0.01%	1259
2022 Q2	$168K	Buy	+17,279	New	+$169K	﹤0.01%	1245
2022 Q1	–	Sell	-8,923	Closed	-$86K	–	2610
2021 Q4	$86K	Sell	8,923 -2,087	-19%	-$20.3K	﹤0.01%	1398
2021 Q3	$107K	Buy	11,010 +6,094	+124%	+$58.7K	﹤0.01%	1284
2021 Q2	$47K	Buy	+4,916	New	+$48K	﹤0.01%	1697

Wolverine Asset Management's MSAC Position: Q1 2023 in Review

Wolverine Asset Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 29,560 shares — an estimated $298K sold.

Wolverine Asset Management first reported a position in MSAC in Q2 2021 and held it in 6 quarters. The position peaked at $298K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Wolverine Asset Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Wolverine Asset Management sold 29,560 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $298K.
Wolverine Asset Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 6 quarters.
Wolverine Asset Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $298K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.